Abridge vs DeepScribe vs Heidi Health vs Nabla
A side-by-side look at scores, pricing and features — with RECATOOLS' ASEAN-aware verdict for each.
Abridge
Ambient AI scribe for clinicians — 200+ health systems, Best in KLAS
Visit
|
DeepScribe
Specialty-focused ambient scribe with built-in coding, enterprise-only
Visit
|
|
Nabla
Ambient AI scribe that turns patient visits into clinical notes.
Visit
|
|
|---|---|---|---|---|
| RECATOOLS Score | 8.2 / 10 | 7.2 / 10 | 8 / 10 | 8.2 / 10 |
| Capability | ||||
| Value for money | ||||
| Ease of use | ||||
| ASEAN readiness | ||||
| API quality | ||||
| Pricing | Enterprise | Enterprise | Freemium | Freemium |
| Free tier | None — enterprise contracts only, no self-serve or trial tier | — | — | Free trial available with core documentation features and limited usage |
| Paid from | Enterprise quote only; no public self-serve pricing (12-month minimum) | — | — | Free tier (up to 30 consultations/mo); Pro ~$119/month (unlimited); enterprise via contract |
| Has API | ✗ | ✗ | ✗ | ✓ |
| Open source | ✗ | ✗ | ✗ | ✗ |
| Free to use | ✗ | ✗ | ✓ | ✗ |
| Users | 200+ health systems; ~50-80M clinical conversations/year | — | — | 85,000+ clinicians across 150+ health organisations (mid-2025) |
| Founded | 2018 | — | — | 2018 |
| Maker | Abridge AI, Inc. (independent) | — | — | Nabla Technologies |
| Verdict | Abridge is the clear market leader in ambient AI documentation for large US health systems, validated by more peer-reviewed research than any competitor, Best in KLAS two consecutive years, and deployments at the most pr... |
DeepScribe's pitch goes past note-taking into revenue cycle: automated E/M, ICD-10, and HCC coding alongside the transcript, plus a pre-visit context tool (SmartPrep) and deep specialty/oncology templates that generalist... |
Heidi's strength is reach: broad EHR support, real multilingual accuracy, quick onboarding, and a genuinely usable free tier for low-volume use — reasons it's become one of the default scribes clinicians in Australia, th... |
Nabla has the best clinical evidence in ambient scribing: a NEJM AI randomized trial across 238 physicians and 48,000+ visits found a statistically significant 9.5% cut in documentation time. Real deployments back it up... |
| Full review → | Full review → | Full review → | Full review → |
Comparisons cover up to 4 tools. Scores are RECATOOLS editorial assessments; verify current pricing on each vendor's site.